Skip to main content
SpringerLink
Log in

Risk of falls and fractures does not necessarily preclude the use of antihypertensive medications

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Antihypertensive medications can cause symptoms of orthostatic hypotension and are therefore hypothesized to independently increase the risk of falls and fall-related injuries such as bone fractures. For this reason, their use is sometimes avoided or discontinued in older people who are at risk. However, evidence regarding the association of antihypertensive medications with fracture risk is inconclusive, with some studies even suggesting a protective benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Velliou M, Sanidas E, Zografou A, et al. Antihypertensive drugs and risk of bone fractures. Drugs Aging. 2022;39(7):551–7.

    Article  CAS  PubMed  Google Scholar 

  2. Rivasi G, Rafanelli M, Mossello E, et al. Drug-related orthostatic hypotension: beyond anti-hypertensive medications. Drugs Aging. 2020;37(10):725–38.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Shea C, Witham MD. Association between the use of angiotensin-blocking medications with hip fracture and death in older people. J Frailty Aging. 2020;9(2):107–10.

    PubMed  Google Scholar 

  4. Langerhuizen DWG, Verweij LPE, Wouden JC, et al. Antihypertensive drugs demonstrate varying levels of hip fracture risk: a systematic review and meta-analysis. Injury. 2021;53(3):1098–107.

    Article  PubMed  Google Scholar 

  5. Tinetti ME, Han L, Lee DS, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–95.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Callisaya ML, Sharman JE, Close J, et al. Greater daily defined dose of antihypertensive medication increases the risk of falls in older people–a population-based study. J Am Geriatr Soc. 2014;62(8):1527–33.

    Article  PubMed  Google Scholar 

  7. Kahlaee HR, Latt MD, Schneider CR. Association between chronic or acute use of antihypertensive class of medications and falls in older adults. A systematic review and meta-analysis. Am J Hypertens. 2018;31(4):467–79.

    Article  CAS  PubMed  Google Scholar 

  8. Williamson JD, Supiano MA, Pajewski NM. Intensive vs standard blood pressure control for older adults-reply. JAMA. 2016;316(18):1923.

    Article  PubMed  Google Scholar 

  9. Albasri A, Hattle M, Koshiaris C, et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. 2021;372:n189.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Xiao F, Qu X, Zhai Z, et al. Association between loop diuretic use and fracture risk. Osteoporos Int. 2015;26(2):775–84.

    Article  CAS  PubMed  Google Scholar 

  11. Torstensson M, Hansen AH, Leth-Moller K, et al. Danish register-based study on the association between specific cardiovascular drugs and fragility fractures. BMJ Open. 2015;5(12):e009522.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Wang J, Su K, Sang W, et al. Thiazide diuretics and the incidence of osteoporotic fracture: a systematic review and meta-analysis of cohort studies. Front Pharmacol. 2019;10:1364.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Cheng YZ, Huang ZZ, Shen ZF, et al. ACE inhibitors and the risk of fractures: a meta-analysis of observational studies. Endocrine. 2017;55(3):732–40.

    Article  CAS  PubMed  Google Scholar 

  14. Carbone LD, Vasan S, Prentice RL, et al. The renin-angiotensin aldosterone system and osteoporosis: findings from the Women’s Health Initiative. Osteoporos Int. 2019;30(10):2039–56.

    Article  CAS  PubMed  Google Scholar 

  15. Kunutsor SK, Blom AW, Whitehouse MR, et al. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies. Eur J Epidemiol. 2017;32(11):947–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bokrantz T, Schioler L, Bostrom KB, et al. Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database. J Hypertens. 2020;38(1):167–75.

    Article  CAS  PubMed  Google Scholar 

  17. Hargrove JL, Golightly YM, Pate V, et al. Initiation of antihypertensive monotherapy and incident fractures among Medicare beneficiaries. Inj Epidemiol. 2017;4(1):27.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Takaoka S, Yamaguchi T, Tanaka K, et al. Fracture risk is increased by the complication of hypertension and treatment with calcium channel blockers in postmenopausal women with type 2 diabetes. J Bone Miner Metab. 2013;31(1):102–7.

    Article  CAS  PubMed  Google Scholar 

  19. Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens. 2006;24(3):581–9.

    Article  CAS  PubMed  Google Scholar 

  20. Bursztyn M. Hypertension, its treatment, frailty, falls, and mortality. Hypertension. 2017;70(2):253–4.

    Article  CAS  PubMed  Google Scholar 

  21. Bromfield SG, Ngameni CA, Colantonio LD, et al. Blood pressure, antihypertensive polypharmacy, frailty, and risk for serious fall injuries among older treated adults with hypertension. Hypertension. 2017;70(2):259–66.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand

    Esther S. Kim & Connie Kang

Authors
  1. Esther S. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Connie Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Connie Kang.

Ethics declarations

Funding

The preparation of this review was not supported by any external funding.

Authorship and conflict of interest

E. S. Kim, a contracted employee of Adis International Ltd/Springer Nature, and C. Kang, a salaried employee of Adis International Ltd/Springer Nature, declare no relevant conflicts of interest. All authors contributed to the review and are responsible for the article content.

Ethics approval, Consent to participate, Consent for publication, Availability of data and material, Code availability

Not applicable.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, E.S., Kang, C. Risk of falls and fractures does not necessarily preclude the use of antihypertensive medications. Drugs Ther Perspect 39, 212–215 (2023). https://doi.org/10.1007/s40267-023-00999-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-023-00999-x

Search

Navigation